Clinical Trials in Baltimore

Showing 7121-7140 of 17,842 trials

Cannabidiol Oral Solution for the Treatment of Patients With Prader-Willi Syndrome

NCT02844933

The primary objective of this study is to assess the efficacy of cannabidiol oral solution on hyperphagia-related behavior in patients with Prader-Willi Syndrome (PWS). The secondary objectives of this study are to assess the efficacy, safety and tolerability, impact on quality of life, and impact on physical activity of cannabidiol oral solution in patients with PWS.

Prader-Willi Syndrome

Radius Pharmaceuticals, Inc.7 participantsStarted May 2018

Tucson, Arizona, United States • San Diego, California, United States • Iowa City, Iowa, United States +4 more locations

COMPLETEDPhase 3< 1 mile

A Study of Carboplatin Plus Etoposide With or Without Atezolizumab in Participants With Untreated Extensive-Stage (ES) Small Cell Lung Cancer (SCLC)

NCT02763579

This randomized, Phase I/III, multicenter, double-blinded, placebo-controlled study was designed to evaluate the safety and efficacy of atezolizumab (anti-programmed death-ligand 1 \[PD-L1\] antibody) in combination with carboplatin plus (+) etoposide compared with treatment with placebo + carboplatin + etoposide in chemotherapy-naive participants with ES-SCLC. Participants will be randomized in a 1:1 ratio to receive either atezolizumab + carboplatin + etoposide or placebo + carboplatin + etoposide on 21-day cycles for four cycles in the induction phase followed by maintenance with atezolizumab or placebo until progressive disease (PD) as assessed by the investigator using Response Evaluation Criteria in Solid Tumors Version 1.1 (RECIST v1.1). Treatment can be continued until persistent radiographic PD or symptomatic deterioration.

Small Cell Lung Carcinoma

Hoffmann-La Roche503 participantsStarted Jun 2016

Fort Myers, Florida, United States • Orlando, Florida, United States • St. Petersburg, Florida, United States +111 more locations

Cannabidiol Oral Solution for the Treatment of Patients With Prader-Willi Syndrome

A Study of Carboplatin Plus Etoposide With or Without Atezolizumab in Participants With Untreated Extensive-Stage (ES) Small Cell Lung Cancer (SCLC)

Find Trials by Condition in Baltimore

Hyperthermia Treatment Added to Chemotherapy Standard of Care for Pancreatic Tumors

Safety, Tolerability, and Immunogenicity of V114 in Healthy Infants (V114-029)

Feasibility and Preliminary Efficacy of a Mindfulness-based Intervention for Children and Young Adults With High Grade or High-Risk Cancer and Their Caregivers

Long-Chain Fatty Acid Oxidation Disorders (LC-FAOD) Extension Study for Subjects Previously Enrolled in Triheptanoin Studies

Real-World Evidence of Duration of Effect of Adhansia XR (Extended-Release) for Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD)

AGN-151586 Dose-Ranging Study for Treatment of Glabellar Lines

Enapotamab Vedotin (HuMax-AXL-ADC) Safety Study in Patients With Solid Tumors

Groningen International Study on Sentinel Nodes in Vulvar Cancer-III

A Study of PRN1008 in Patients With Pemphigus

enLighten Laser With MLA Handpiece for Treatment of Moderate and Severe Acne Scars

Evaluation of C-Scan Capsule in Identifying Subjects With Elevated Risk of Colon Polyps

Evaluation of Rotation With a Multifocal Toric Contact Lens

A Study of AZD0466 in Patients With Advanced Hematologic or Solid Tumors

A Study to Assess the Efficacy, Safety and Tolerability of Rozanolixizumab in Subjects With Chronic Inflammatory Demyelinating Polyradiculoneuropathy

Study of MK-8353 + Selumetinib in Advanced/Metastatic Solid Tumors (MK-8353-014)

A Technology Assisted Care Transition Intervention for Veterans With CHF or COPD

Fulvestrant + Neratinib In Breast Cancer

A Six-Month Follow-Up Study of Participants With Coronavirus Disease 2019 (COVID-19) Previously Enrolled in a RO7496998 (AT-527) Study